Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis-Reference-Cited by-同舟云学术

Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis

Published:2007 Issue:2 Volume:46 Page:388-394
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Buster Erik H. C. J.,Hansen Bettina E.,Buti Maria,Delwaide Jean,Niederau Claus,Michielsen Peter P.,Flisiak Robert,Zondervan Pieter E.,Schalm Solko W.,Janssen Harry L. A.,

Publisher

Wiley

Subject

Hepatology

Reference29 articles.

1. Viral hepatitis B

2. Immunopathogenesis of hepatitis B

3. Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

4. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B

5. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The performance of hepatitis B surface antigen quantification as a noninvasive biomarker predicting liver injury and serum hepatitis B virus DNA level;European Journal of Gastroenterology & Hepatology;2023-12-11

2. Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients;Infection and Drug Resistance;2023-06

3. No differences in the risk of hepatocellular carcinoma from using direct-acting antiviral agents or interferon in patients with chronic hepatitis C: A meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2022-12

4. Interferon‐based treatment of chronic hepatitis D;Liver International;2022-09-02

5. An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients;Frontiers in Microbiology;2022-08-30